Novavax, Inc. (NVAX)

Novavax Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	2,402	570	884	10,817	4,079	93
Market Cap Growth	12.02%	-35.49%	-91.83%	165.20%	4270.56%	-86.75%
Enterprise Value	2,141	178	300	9,339	4,230	354
Last Close Price	4.78	4.80	10.28	143.07	111.51	3.98
PE Ratio	-	-0.89	-1.22	-6.10	-15.34	-0.72
PS Ratio	2.41	0.58	0.45	9.44	8.58	5.00
PB Ratio	-0.77	-0.80	-1.39	-30.76	6.50	-0.50
P/FCF Ratio	-1.30	-0.74	-1.75	40.30	-42.04	-0.67
P/OCF Ratio	-1.42	-0.80	-2.12	33.50	-95.88	-0.68
EV/Sales Ratio	2.15	0.18	0.15	8.15	8.89	18.96
EV/EBITDA Ratio	-1.14	-0.35	-0.49	-5.58	-10.34	-2.86
EV/EBIT Ratio	-1.01	-0.32	-0.47	-5.54	-10.22	-2.73
EV/FCF Ratio	-0.74	-0.23	-0.59	34.79	-43.61	-2.56
Debt / Equity Ratio	-0.67	-0.39	-0.97	-1.49	0.77	-1.73
Debt / FCF Ratio	-1.13	-0.37	-1.22	1.95	-4.97	-2.32
Asset Turnover	0.69	0.49	0.82	0.55	0.54	0.10
Inventory Turnover	37.93	27.52	93.86	-	-	-
Quick Ratio	0.62	0.53	0.58	0.82	1.68	3.35
Current Ratio	0.90	0.70	0.69	0.90	2.15	3.77
Return on Equity (ROE)	-	-	-	-1265.72%	-189.60%	-
Return on Assets (ROA)	-16.32%	-17.02%	-16.67%	-50.69%	-29.48%	-42.53%
Return on Capital (ROIC)	-	-	-519.71%	-164.51%	-41.57%	-56.42%
Earnings Yield	-16.60%	-95.59%	-74.44%	-16.12%	-10.25%	-142.18%
FCF Yield	-21.41%	-134.65%	-57.13%	2.48%	-2.38%	-148.38%
Buyback Yield / Dilution	-62.39%	-28.89%	-5.08%	-29.27%	-138.81%	-30.35%
Total Shareholder Return	-62.39%	-28.89%	-5.08%	-29.27%	-138.81%	-30.35%

Source: S&P Capital IQ. Standard template.